Summit Biosciences

Lexington, United States Founded: 2008 • Age: 18 yrs Acquired By Kindeva Drug Delivery
Nasal spray drug products are developed, manufactured, and commercialized.

About Summit Biosciences

Summit Biosciences is a Healthcare company based in Lexington (United States) founded in 2008 by Edwin Cohen, and was acquired by Kindeva Drug Delivery in January 2024. Nasal spray drug products are developed, manufactured, and commercialized. Its chief executive, as recorded, is Edwin Cohen. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Exela Pharma, ApiJect and August Bioservices; 3 of its 3 listed competitors have raised funding.

Company details

Summit Biosciences was founded in 2008 in Lexington, United States, as a specialty pharmaceutical company. Generic and innovative nasal spray products are developed, manufactured, and commercialized by the firm. Contract development and manufacturing services are also provided to partners for various nasally delivered drugs and systems. The facility is FDA-approved, DEA-registered, and compliant with cGMP standards, supporting product development from concept through to commercialization.

Key Metrics

Investors in Summit Biosciences

Summit Biosciences has secured backing from 1 investor. Prominent investors backing the company include Kindeva Drug Delivery.

All
InvestorDescriptionFounded YearDomainLocation
Injectables and biologics products are manufactured by the CDMO.
2020kindevadd.comSaint Paul, United States
Premium access

Investor details for Summit Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Summit Biosciences

23 people are tracked at Summit Biosciences (5 in leadership, 4 in board & advisors, 14 in team).

NameRoleGroup
Edwin Cohen
Founder & CEOLeadership
Bill Greiner
Director of OperationsLeadership
Sonia L. Egbert
CFOLeadership
Edwin A. Cohen
CEOLeadership
Gregory G. Plucinski
President & COOLeadership
Robert Saunders
DirectorBoard & advisors
William Lomicka
DirectorBoard & advisors
R. Charles Moyer
DirectorBoard & advisors
Richard D. Cohen
ChairmanBoard & advisors
Ted A. Marcuccio
CBOTeam
Erin Ashley
Quality Control Shift LeadTeam
Jennifer Withers
Accounting & Human Resource SpecialistTeam
Katrina Lamb
QC Microbiology CoordinatorTeam
Patrick Gagnon
Shift LeadTeam
Adam Hankins
Senior Manager, Quality Control MicrobiologyTeam
Stephanie Lathrop
Project ManagementTeam
Jeremy McFarland
Senior Project EngineerTeam
Ashley Gumm, CAPM®
Project Management AssociateTeam
Tim Norris
Manufacturing Shift LeadTeam
Laura Valdes
Principal MicrobiologistTeam

3 more people are available in the full profile.

Premium access

Complete people profiles for Summit Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Summit Biosciences

2 dated milestones of Summit Biosciences across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Summit Biosciences is founded.
  2. Exit Acquired by Kindeva Drug Delivery.

Competitors of Summit Biosciences

Summit Biosciences has 3 listed competitors in our database, 3 of them funded. They include Exela Pharma, ApiJect and August Bioservices.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
exelapharma.com2005Lenoir, United States$7.09M247
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
apiject.com2015Stamford, United States$111M
Medicine injectors are manufactured by ApiJect for medical applications.
augustbio.com2017Nashville, United States$88.6M86
Diversified research services for clinical solutions are offered.
Premium access

Detailed competitors of Summit Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Summit Biosciences

Websites that share an audience with Summit Biosciences (summitbiosciences.com).

Similar websites

Websites whose visitors overlap most with Summit Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
reddit.com
100%
4.4B#9View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Summit Biosciences (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Summit Biosciences

Premium access

Complete news archive for Summit Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Summit Biosciences

Summit Biosciences was founded in 2008.

Summit Biosciences is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Edwin Cohen is the CEO of Summit Biosciences, as recorded in our data. They have also founded this company.

Summit Biosciences was founded in 2008 in Lexington, United States, as a specialty pharmaceutical company. Generic and innovative nasal spray products are developed, manufactured, and commercialized by the firm. Contract development and manufacturing services are also provided to partners for various nasally delivered drugs and systems. The facility is FDA-approved, DEA-registered, and compliant with cGMP standards, supporting product development from concept through to commercialization.

Summit Biosciences's top competitors include Exela Pharma, August Bioservices and ApiJect.

Summit Biosciences has 1 investor. Key investors include Kindeva Drug Delivery.

Yes. Summit Biosciences was acquired by Kindeva Drug Delivery in January 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available